CHCHD2 and nasopharyngeal carcinoma: Immunohistochemical analysis revealed the decreased expression of Ki67 and CHCHD2 in the hellebrigenin‐treated group, which reflected that hellebrigenin inhibited the tumourigenesis of NPC (Figure 6I).